Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice

Journal of Neuroscience

Volumn 21, Issue 21, 2001, Pages 8473-8481

  Li, He ^a,c   Li, Shi Hua ^a   Yu, Zhao Xue ^a   Shelbourne, Peggy ^b   Li, Xiao Jiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Axon; Degeneration; Huntingtin; Mitochondria; Polyglutamine; Transport

Indexed keywords

DNA FRAGMENT; HUNTINGTIN; MUTANT PROTEIN; POLYGLUTAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS INCLUSION BODY; GLOBUS PALLIDUS; HUNTINGTON CHOREA; MOUSE; MOUSE MUTANT; NERVE CELL CULTURE; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NERVE PROJECTION; NEUROPATHOLOGY; NEUROPIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; STRIATE CORTEX; SUBSTANTIA NIGRA;

EID: 0035503511     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-21-08473.2001     Document Type: Article

References (50)

1. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease
2. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease
3. Magnetic resonance spectroscopy: Imaging axonal damage in MS
4. Energetics in the pathogenesis of neurodegenerative diseases
5. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
6. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene
7. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
8. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
9. Studies on the mechanisms of autophagy: Formation of the autophagic vacuole
10. Selective sparing of a class of striatal neurons in Huntington's disease
11. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease
12. Neurotransmitters and neuromodulators in the basal ganglia
13. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
14. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
15. Genetic suppression of polyglutamine toxicity in Drosophila
16. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy
17. Dramatic mutation instability in HD mouse striatum: Does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
18. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
19. Huntington aggregates may not predict neuronal death in Huntington's disease
20. Enhanced sensitivity to N-methyl-D -aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease
21. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice
22. Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin
23. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity
24. Expression of huntingtinassociated protein-1 in neuronal cells implicates a role in neuritic growth
25. Myelinated axon undergoes complete demyelination in the panencephalopathic -but it is merely subjected to the Wallerian degeneration in the polioencephalopathic type of transmissible spongiform encephalopathies
26. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
27. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
28. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells
29. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation
30. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity
31. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
32. Differential loss of striatal projection neurons in Huntington disease
33. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients
34. Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study
35. Caspase-8 is required for cell death induced by expanded polyglutamine repeats
36. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease
37. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
38. Increased apoptosis of Huntington disease lymphoblasts associated with repeat lengthdependent mitochondrial depolarization
39. MRI demonstration of Wallerian degeneration in various intracranial lesions and its clinical implications
40. Mitochondrial involvement in Parkinson's disease. Huntington's disease, hereditary spastic paraplegia, and Friedreich's ataxia
41. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
42. A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice
43. Motor disorder in Huntington's disease begins as a dysfunction in error feedback control
44. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse
45. Axonal pathology in multiple sclerosis: Relationship to neurologic disability
46. Acute and chronic neuropathies: New aspects of Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy, an overview and an update
47. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation
48. Neuropathological classification of Huntington's disease
49. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70
50. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice